Mixing Insulin Glargine With Rapid-Acting Insulin: A Review of the Literature
نویسندگان
چکیده
منابع مشابه
Mixing Insulin Glargine With Rapid-Acting Insulin: A Review of the Literature
Address correspondence to Dana G. Carroll, PharmD, BCPS, CDE, 850 5th Avenue East, Tuscaloosa, AL 35401. Mixing Insulin Glargine With Rapid-Acting Insulin: A Review of the Literature Dana G. Carroll, PharmD, BCPS, CDE, and Lisa Meade, PharmD, CDE Purpose. To review the literature examining the mixing of insulin glargine with rapid-acting insulin (RAI). Methods. A literature search was conducted...
متن کاملInsulin glargine: a long acting insulin analog.
The main goal of treatment of diabetes mellitus (DM) is to maintain long term near normoglycemia. Insulin therapy plays a pivotal role in the management of DM. Most insulin preparations and insulin delivery systems, do not mimic the physiological insulin secretion in the body, leading to impaired metabolic control and increased hypoglycemic attacks. Insulin glargine is newer, long acting insuli...
متن کاملInsulin glargine: a long-acting insulin for diabetes mellitus.
Insulin glargine is a once-daily, biosynthetic, human insulin analogue. Some trials show that in patients with type 1 diabetes mellitus, insulin glargine offers an advantage in blood glucose control compared with NPH insulin. There is some evidence of decreased nocturnal and symptomatic hypoglycemia in patients receiving insulin glargine compared with those receiving NPH insulin, but there are ...
متن کاملSystematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
OBJECTIVES To evaluate the use of insulin glargine in its licensed basal-bolus indication in terms of both clinical and cost-effectiveness. DATA SOURCES Electronic databases. REVIEW METHODS A systematic review of the literature, involving a range of databases, was performed to identify all papers relating to insulin glargine. RESULTS Nineteen studies met the inclusion criteria but full re...
متن کاملRapid Acting Insulin Analogues
Different kinds of insulin analogues, both short acting as well as long acting, are now available which offer several benefits over human insulins including improved physiologic profile, greater convenience, reduced risk of hypoglycemia and, in some instances, less weight gain. Combined, these elements may increase a patient’s adherence to treatment, potentially increasing the level of glycemic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Spectrum
سال: 2013
ISSN: 1040-9165,1944-7353
DOI: 10.2337/diaspect.26.2.112